Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicent Fonollosa-Pla

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Medicina Clinica|September 8, 2015
[Pulmonary hypertension in scleroderma]Vicent Fonollosa-Pla, Carmen Pilar Simeón-Aznar
Medicina Clinica|April 7, 2004
[Scleroderma]Vicent Fonollosa Pla, Carmen Pilar Simeón Aznar
Nature Reviews. Rheumatology|April 14, 2010
Targeted therapy for systemic sclerosis: how close are we?Manuel Ramos-Casals, Vicent Fonollosa-Pla, Pilar Brito-Zerón, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Understanding the Role of Antibodies as Markers of Cancer-Associated Systemic Sclerosis: Comment on the Article by Shah et alDavid Bernal-Bello, Alfredo Guillén-Del Castillo, Albert Selva-O'Callaghan, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndromeIago Pinal-Fernandez, Esther Pallisa-Nuñez, Albert Selva-O'Callaghan, et al.
Autoimmunity Reviews|March 13, 2017
Novel risk factors related to cancer in sclerodermaDavid Bernal-Bello, Jaime García de Tena, Alfredo Guillén-Del Castillo, et al.
Seminars in Arthritis and Rheumatism|August 12, 2014
Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibodyAlfredo Guillen-Del Castillo, Carmen Pilar Simeón-Aznar, Vicent Fonollosa-Pla, et al.
Diagnostics (Basel, Switzerland)|April 13, 2023
Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative ReviewMarvin J Fritzler, Chelsea Bentow, Lorenzo Beretta, et al.
Clinical and Experimental Rheumatology|September 1, 2012
Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regionsRaquel Rios-Fernández, Jose-Luis Callejas-Rubio, Concepción Fernández-Roldán, et al.
Clinical and Experimental Rheumatology|February 24, 2017
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)Manuel Rubio-Rivas, Carmen Pilar Simeón-Aznar, César Velasco, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Medicina Clinica|September 8, 2015
[Pulmonary hypertension in scleroderma]Vicent Fonollosa-Pla, Carmen Pilar Simeón-Aznar
Medicina Clinica|April 7, 2004
[Scleroderma]Vicent Fonollosa Pla, Carmen Pilar Simeón Aznar
Nature Reviews. Rheumatology|April 14, 2010
Targeted therapy for systemic sclerosis: how close are we?Manuel Ramos-Casals, Vicent Fonollosa-Pla, Pilar Brito-Zerón, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Understanding the Role of Antibodies as Markers of Cancer-Associated Systemic Sclerosis: Comment on the Article by Shah et alDavid Bernal-Bello, Alfredo Guillén-Del Castillo, Albert Selva-O'Callaghan, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndromeIago Pinal-Fernandez, Esther Pallisa-Nuñez, Albert Selva-O'Callaghan, et al.
Autoimmunity Reviews|March 13, 2017
Novel risk factors related to cancer in sclerodermaDavid Bernal-Bello, Jaime García de Tena, Alfredo Guillén-Del Castillo, et al.
Seminars in Arthritis and Rheumatism|August 12, 2014
Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibodyAlfredo Guillen-Del Castillo, Carmen Pilar Simeón-Aznar, Vicent Fonollosa-Pla, et al.
Diagnostics (Basel, Switzerland)|April 13, 2023
Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative ReviewMarvin J Fritzler, Chelsea Bentow, Lorenzo Beretta, et al.
Clinical and Experimental Rheumatology|September 1, 2012
Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regionsRaquel Rios-Fernández, Jose-Luis Callejas-Rubio, Concepción Fernández-Roldán, et al.
Clinical and Experimental Rheumatology|February 24, 2017
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)Manuel Rubio-Rivas, Carmen Pilar Simeón-Aznar, César Velasco, et al.
Pageof 4